EXHIBIT # 10.47
AMENDMENT NO. 1 TO THE
12% CONVERTIBLE SECURED PROMISSORY NOTE
This Amendment No. 1 to the 12% Convertible Secured Promissory Note, dated as of July 31, 2003 (this
"Amendment"), is to the 12% Convertible Secured Promissory Note, dated _________________, 2003 in the
principal amount of $__________________(the "Note"), issued by Molecular Diagnostics, Inc., a Delaware
corporation (the "Company") to _______________________ ("Investor").
WHEREAS, Investor purchased the Note from the Company in connection with a bridge financing in the
aggregate principal amount of up to $4,000,000;
WHEREAS, Investor purchased the Note from the Company pursuant to certain financing documents, including
a Note Subscription Agreement, Indenture, Security Agreement, Collateral Sharing Agreement, Warrant to
Purchase Shares of Common Stock and the Note (collectively, the "Financing Documents");
WHEREAS, pursuant to the terms of the Financing Documents, the total outstanding principal balance and
accrued and unpaid interest on the Note were due July 31, 2003;
WHEREAS, pursuant to and in compliance with the provisions of Section 17 of the Note, the Company and
Investor desire to amend the Note as hereinafter set forth.
NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, the Company and Investor agree as follows:
1. The first two sentences of Section 1 shall be deleted and replaced in their entirety with the following:
"The unpaid principal balance of this Note shall bear simple interest at the rate of twelve percent (12%) per
annum from the date hereof until July 31, 2003. After July 31, 2003, the unpaid principal balance of this Note
shall bear simple interest at the rate of fifteen percent (15%) per annum."
2. Section 2 is amended by deleting the date "July 31, 2003" and inserting the new date of "July 31, 2004."
3. Investor hereby waives any Events of Defaults by the Company under the Financing Documents.